Lineage Cell Therapeutics (LCTX) had the highest return on October 12, 2007 by a US stock, returning 50%.

ASSET	DATE	% RETURN
Lineage Cell Therapeutics (LCTX)	10/12/2007	50.04%
LifeMD (LFMD)	10/12/2007	50%
China Pharma (CPHI)	10/12/2007	22.43%
Champions Oncology (CSBR)	10/12/2007	17.65%
Firefly Neuroscience (AIFF)	10/12/2007	17.14%
Protagenic Therapeutics (PTIX)	10/12/2007	16%
Energy Focu (EFOI)	10/12/2007	13.68%
Westwater Resources (WWR)	10/12/2007	12.61%
Galectin Therapeutics (GALT)	10/12/2007	11.42%
Cyanotech (CYAN)	10/12/2007	11.11%
Cal-Maine Foods (CALM)	10/12/2007	10.72%
Cryoport (CYRX)	10/12/2007	10.62%
Cemtrex (CETX)	10/12/2007	9.62%
Caledonia Mining (CMCL)	10/12/2007	9.19%
ImmuCell (ICCC)	10/12/2007	9.16%
TG Therapeutics (TGTX)	10/12/2007	9.05%
Transcat (TRNS)	10/12/2007	8.7%
Alterity Therapeutics (ATHE)	10/12/2007	8.57%
Richardson Electronics (RELL)	10/12/2007	8.45%
Taitron Components (TAIT)	10/12/2007	8.38%
Cerus (CERS)	10/12/2007	8.3%
Idaho Strategic Resources (IDR)	10/12/2007	7.69%
Acadia Healthcare (ACHC)	10/12/2007	7.66%
Seabridge Gold (SA)	10/12/2007	7.61%
Capstone Holding Corp Common Stock (CAPS)	10/12/2007	7.59%